Peter Wirsching

2.9k total citations
51 papers, 2.2k citations indexed

About

Peter Wirsching is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry. According to data from OpenAlex, Peter Wirsching has authored 51 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 23 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Organic Chemistry. Recurrent topics in Peter Wirsching's work include Monoclonal and Polyclonal Antibodies Research (23 papers), Chemical Synthesis and Analysis (14 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Peter Wirsching is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (23 papers), Chemical Synthesis and Analysis (14 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Peter Wirsching collaborates with scholars based in United States, France and Australia. Peter Wirsching's co-authors include Kim D. Janda, Jon Ashley, Richard A. Lerner, Masayuki Matsushita, George F. Koob, M. Rocı́o A. Carrera, Changshou Gao, Shenlan Mao, Michaël M. Meijler and Bin Zhou and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter Wirsching

51 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Wirsching United States 28 1.3k 720 401 358 264 51 2.2k
Oliver Zerbe Switzerland 37 2.5k 1.9× 284 0.4× 626 1.6× 478 1.3× 215 0.8× 145 4.0k
Markus Muttenthaler Australia 28 2.6k 2.0× 203 0.3× 697 1.7× 431 1.2× 108 0.4× 66 3.7k
Ku‐Lung Hsu United States 29 1.6k 1.2× 277 0.4× 785 2.0× 284 0.8× 122 0.5× 82 2.7k
Moriz Mayer Austria 19 3.1k 2.3× 371 0.5× 604 1.5× 1.2k 3.3× 503 1.9× 42 4.3k
Hiroaki Gouda Japan 23 1.5k 1.1× 185 0.3× 390 1.0× 198 0.6× 105 0.4× 84 2.3k
Maikel Wijtmans Netherlands 29 1.3k 0.9× 174 0.2× 563 1.4× 292 0.8× 220 0.8× 81 2.4k
Roger Freidinger United States 37 3.5k 2.6× 421 0.6× 2.4k 6.1× 1.1k 3.1× 237 0.9× 121 5.9k
Pavel Majer Czechia 31 1.6k 1.2× 418 0.6× 565 1.4× 377 1.1× 227 0.9× 117 3.3k
Georgia B. McGaughey United States 23 1.5k 1.1× 115 0.2× 682 1.7× 154 0.4× 209 0.8× 56 2.8k
George L. Trainor United States 37 2.3k 1.7× 85 0.1× 1.6k 4.1× 124 0.3× 244 0.9× 83 4.5k

Countries citing papers authored by Peter Wirsching

Since Specialization
Citations

This map shows the geographic impact of Peter Wirsching's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wirsching with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wirsching more than expected).

Fields of papers citing papers by Peter Wirsching

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Wirsching. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wirsching. The network helps show where Peter Wirsching may publish in the future.

Co-authorship network of co-authors of Peter Wirsching

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Wirsching. A scholar is included among the top collaborators of Peter Wirsching based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Wirsching. Peter Wirsching is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Funk, Colin, et al.. (2007). MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacology Biochemistry and Behavior. 88(4). 497–510. 77 indexed citations
2.
Yamamoto, Noboru, Michaël M. Meijler, Peter Wirsching, et al.. (2005). Chiral sensing using a blue fluorescent antibody. Molecular BioSystems. 1(4). 303–306. 24 indexed citations
3.
Trigo, José, et al.. (2005). Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdose. Pharmacology Biochemistry and Behavior. 81(4). 709–714. 30 indexed citations
4.
Meijler, Michaël M., Masayuki Matsushita, Peter Wirsching, & Kim D. Janda. (2004). Development of Immunopharmacotherapy Against Drugs of Abuse. Current Drug Discovery Technologies. 1(1). 77–89. 35 indexed citations
5.
Sun, Chengzao, Peter Wirsching, & Kim D. Janda. (2003). Enabling ScFvs as multi-drug carriers: A dendritic approach. Bioorganic & Medicinal Chemistry. 11(8). 1761–1768. 13 indexed citations
6.
Redwan, Elrashdy M., Nicholas Larsen, Bin Zhou, et al.. (2003). Expression and characterization of a humanized cocaine‐binding antibody. Biotechnology and Bioengineering. 82(5). 612–618. 18 indexed citations
7.
Hoffman, Timothy Z., et al.. (2002). Synthesis, Properties, and Reactivity of Cocaine Benzoylthio Ester Possessing the Cocaine Absolute Configuration. Journal of the American Chemical Society. 124(14). 3661–3668. 14 indexed citations
8.
Zhou, Bin, Peter Wirsching, & Kim D. Janda. (2002). Human antibodies against spores of the genus Bacillus : A model study for detection of and protection against anthrax and the bioterrorist threat. Proceedings of the National Academy of Sciences. 99(8). 5241–5246. 47 indexed citations
9.
Sun, Chengzao, Peter Wirsching, & Kim D. Janda. (2002). Syntheses of dendritic linkers containing chlorambucil residues for the preparation of antibody–multidrug immunoconjugates. Bioorganic & Medicinal Chemistry Letters. 12(16). 2213–2215. 6 indexed citations
10.
Ashley, Jon, et al.. (2002). Antibody-catalyzed cleavage of the d-Ala-d-Lac depsipeptide: An immunological approach to the problem of vancomycin resistance. Bioorganic & Medicinal Chemistry Letters. 12(6). 861–864. 8 indexed citations
11.
Larsen, Nicholas, Bin Zhou, A. Heine, et al.. (2001). Crystal structure of a cocaine-binding antibody. Journal of Molecular Biology. 311(1). 9–15. 41 indexed citations
12.
Matsushita, Masayuki, Timothy Z. Hoffman, Jon Ashley, et al.. (2001). Cocaine catalytic antibodies: the primary importance of linker effects. Bioorganic & Medicinal Chemistry Letters. 11(2). 87–90. 47 indexed citations
13.
Carrera, M. Rocı́o A., Jon Ashley, Bin Zhou, et al.. (2000). Cocaine vaccines: Antibody protection against relapse in a rat model. Proceedings of the National Academy of Sciences. 97(11). 6202–6206. 125 indexed citations
14.
Gao, Changshou, Shenlan Mao, Chih‐Hung L. Lo, et al.. (1999). Making artificial antibodies: A format for phage display of combinatorial heterodimeric arrays. Proceedings of the National Academy of Sciences. 96(11). 6025–6030. 111 indexed citations
15.
Lin, Chao‐Hsiung, Timothy Z. Hoffman, Peter Wirsching, et al.. (1997). On roads not taken in the evolution of protein catalysts: Antibody steroid isomerases that use an enamine mechanism. Proceedings of the National Academy of Sciences. 94(22). 11773–11776. 12 indexed citations
16.
Yli‐Kauhaluoma, Jari, et al.. (1996). Catalytic Antibodies with Peptidyl−Prolyl Cis−Trans Isomerase Activity. Journal of the American Chemical Society. 118(23). 5496–5497. 16 indexed citations
17.
Wirsching, Peter, Jon Ashley, Stephen J. Benkovic, Kim D. Janda, & Richard A. Lerner. (1991). An Unexpectedly Efficient Catalytic Antibody Operating by Ping-Pong and Induced Fit Mechanisms. Science. 252(5006). 680–685. 61 indexed citations
18.
Wirsching, Peter & M. H. O'LEARY. (1988). 1-Carboxyallenyl phosphate, an allenic analog of phosphoenolpyruvate. Biochemistry. 27(4). 1355–1360. 16 indexed citations
19.
Wirsching, Peter & Marion H. O’Leary. (1988). (Z)-3-Fluoromethylphosphoenolpyruvate: synthesis and enzymatic studies. Biochemistry. 27(4). 1348–1355. 7 indexed citations
20.
Wirsching, Peter & Marion H. O’Leary. (1985). (E)-3-Cyanophosphoenolpyruvate, a new inhibitor of phosphoenolpyruvate-dependent enzymes. Biochemistry. 24(26). 7602–7606. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver Zerbe Breakdown of academic impact, for papers by Markus Muttenthaler Breakdown of academic impact, for papers by Ku‐Lung Hsu Breakdown of academic impact, for papers by Moriz Mayer Breakdown of academic impact, for papers by Hiroaki Gouda Breakdown of academic impact, for papers by Maikel Wijtmans Breakdown of academic impact, for papers by Roger Freidinger Breakdown of academic impact, for papers by Pavel Majer Breakdown of academic impact, for papers by Georgia B. McGaughey Breakdown of academic impact, for papers by George L. Trainor
Rankless by CCL
2026